Perspectives in Clinical Research
Table of Contents
2011| April-June | Volume 2 | Issue 2
Please wait, loading Google Map...
| EDITORIAL | ||
| Quality of independent review board/ethics committee oversight in clinical trials in India | p. 45 | |
| Anvita Pandiya | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| LEADERSHIP INITIATIVE |  |
|
| Comparative effectiveness research | p. 48 | |
| Chitra Lele | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| PHARMACOVIGILANCE | |
|
| Pharmacovigilance for clinical trials in India: Current practice and areas for reform | p. 49 | |
| Ballari Brahmachari, Melanie Fernandes, Arun Bhatt | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| QUALITY | |
|
 |
Strategies for ensuring quality data from Indian investigational sites | p. 54 |
| Antal K Hajos, Sujal K Kamble | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| Good documentation practice in clinical research | p. 59 | |
| Chitra Bargaje | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| ORIGINAL ARTICLE | |
|
 |
Trend of clinical drug trials in type 2 diabetes mellitus over last decade | p. 64 |
| Rakesh Parikh, Kirti Pandia, Mahesh Goyal, Meenakshi Sharma, MS Dolima | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| MEDICAL WRITING | |
|
| Plagiarism: Why is it such a big issue for medical writers? | p. 67 | |
| Natasha Das, Monica Panjabi | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| ETHICS | |
|
| The Nuremberg Code-A critique | p. 72 | |
| Ravindra B Ghooi | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||
| LETTER TO EDITOR | |
|
| Not only documentation | p. 77 | |
| Viroj Wiwanitkit | ||
| [ABSTRACT] [HTML Full text] [PDF] | ||